ACUTE LEUKEMIA IN REMISSION
Clinical trials for ACUTE LEUKEMIA IN REMISSION explained in plain language.
Never miss a new study
Get alerted when new ACUTE LEUKEMIA IN REMISSION trials appear
Sign up with your email to follow new studies for ACUTE LEUKEMIA IN REMISSION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo aims to shield young transplant patients from dangerous immune attack
Disease control OngoingThis study tests whether adding the drug vorinostat to standard care can prevent graft-versus-host disease (GVHD) in children, adolescents, and young adults receiving a bone marrow or blood stem cell transplant for blood cancers or disorders. About 43 participants will receive vo…
Matched conditions: ACUTE LEUKEMIA IN REMISSION
Phase: PHASE1, PHASE2 • Sponsor: University of Michigan Rogel Cancer Center • Aim: Disease control
Last updated May 17, 2026 00:51 UTC
-
Could a diabetes drug shield the brain? early trial targets cognitive decline
Knowledge-focused TerminatedThis early-phase study looks at whether liraglutide (Saxenda®), a drug used for weight loss, can increase a brain-protective protein called BDNF in people with multiple sclerosis, long-COVID, or acute leukemia (in remission) who also have obesity and memory or thinking problems. …
Matched conditions: ACUTE LEUKEMIA IN REMISSION
Phase: EARLY_PHASE1 • Sponsor: University of Chicago • Aim: Knowledge-focused
Last updated May 15, 2026 11:56 UTC